---
title: "Rishi Techtex Ltd (523021) — Share Price, Financials & Analysis"
symbol: "523021"
company: "Rishi Techtex Ltd"
canonical: "https://tapetide.com/stocks/523021"
isin: "INE989D01010"
nse_symbol: "RISHIPACKERSLTD"
bse_code: "523021"
sector: "Industrial Products"
industry: "Packaging"
market_cap_cr: 29.6
generated_at: "2026-09-13T18:59:05.359Z"
---

# Rishi Techtex Ltd (523021)

Canonical page: https://tapetide.com/stocks/523021

## Company

- **NSE Symbol:** RISHIPACKERSLTD
- **BSE Code:** 523021
- **ISIN:** INE989D01010
- **Sector:** Industrial Products
- **Industry:** Packaging
- **Macro Sector:** Industrials
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** rishitechtex.com

## About

Incorporated in 1984, Rishi Techtex Ltd is in the business of manufacturing Shade nets and Plastic Woven Sacks.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:49:09.233069Z.

- **Market Cap:** ₹29.6 Cr
- **Classification:** Microcap
- **P/E (reported):** 10.8
- **EPS (TTM):** ₹3.71
- **EPS (reported):** ₹1.8
- **Book Value:** ₹49.57
- **Price to Book:** 0.81
- **Dividend Yield:** 0%
- **ROE:** 6.81%
- **ROCE:** 13.77%
- **Debt to Equity:** 0.89
- **Revenue (yearly):** ₹147.3 Cr
- **Net Income:** ₹2.5 Cr
- **EBITDA:** ₹9.9 Cr
- **52-Week High:** ₹55.49
- **52-Week Low:** ₹32
- **RSI (14):** 51.83

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Flat
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 28.93 | 9% |
| growth | 78.27 | 9% |
| momentum | 52.84 | 12% |
| ownership | 50 | 24% |
| quality | 48.88 | 22% |
| valuation | 67.41 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.80 times its book value
- Company is expected to give good quarter

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 6.18% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 26.54% | 10.03% | 30.82% |
| ebitda margin growth | 10.34% | -4.39% | -0.74% | 3.85% |
| net income growth | 80% | 8.7% | 34% | 43% |
| revenue growth | 11.01% | 17% | 11% | 13% |
| roce | — | -11.96% | 5.6% | 12.75% |
| roe | — | 1.19% | 5.92% | 51.67% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 28.29 | 27.72 | 29.76 | 27.46 | 31.09 | 31.49 | 35.58 | 30.28 | 39.25 | 34.75 | 42.68 | 47.31 |
| Expenses | 26.69 | 26.04 | 27.49 | 25.61 | 28.9 | 29.62 | 32.89 | 28.2 | 36.63 | 32.76 | 39.82 | 44.16 |
| Operating Profit | 1.6 | 1.68 | 2.27 | 1.85 | 2.19 | 1.87 | 2.69 | 2.08 | 2.62 | 1.99 | 2.86 | 3.15 |
| OPM % | 5.66 | 6.06 | 7.63 | 6.74 | 7.04 | 5.94 | 7.56 | 6.87 | 6.68 | 5.73 | 6.7 | 6.66 |
| Other Income | 0.04 | 0.06 | 0.07 | 0.08 | 0.05 | 0.09 | 0.09 | 0.12 | 0.11 | 0.09 | 0.07 | 0.09 |
| Interest | 0.69 | 0.68 | 0.67 | 0.69 | 0.65 | 0.65 | 0.66 | 0.54 | 0.57 | 0.61 | 0.81 | 0.77 |
| Depreciation | 0.61 | 0.68 | 0.69 | 0.69 | 0.69 | 0.75 | 0.74 | 0.73 | 0.77 | 0.8 | 1.04 | 1.06 |
| Profit before tax | 0.34 | 0.38 | 0.98 | 0.55 | 0.9 | 0.56 | 1.38 | 0.93 | 1.39 | 0.67 | 1.08 | 1.41 |
| Tax % | 14.71 | 13.16 | 68.37 | 27.27 | 41.11 | 44.64 | 21.74 | 29.03 | 34.53 | 31.34 | 56.48 | 36.17 |
| Net Profit | 0.29 | 0.33 | 0.32 | 0.39 | 0.53 | 0.31 | 1.08 | 0.65 | 0.91 | 0.46 | 0.47 | 0.9 |
| EPS in Rs | 0.39 | 0.45 | 0.43 | 0.53 | 0.72 | 0.42 | 1.46 | 0.88 | 1.23 | 0.62 | 0.64 | 1.22 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 67 | 84 | 76 | 81 | 101 | 107 | 112 | 126 | 147 | 164 |
| Expenses | 60 | 76 | 70 | 76 | 95 | 101 | 104 | 117 | 137 | 153 |
| Operating Profit | 6 | 8 | 6 | 5 | 6 | 6 | 7 | 9 | 10 | 11 |
| OPM % | 9 | 10 | 8 | 6 | 6 | 6 | 7 | 7 | 7 | 6 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 |
| Profit before tax | 3 | 4 | 2 | 1 | 2 | 1 | 2 | 3 | 4 | 5 |
| Tax % | 20 | 28 | 55 | 30 | 37 | 11 | 41 | 32 | 39 | — |
| Net Profit | 3 | 3 | 1 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| EPS in Rs | 3.42 | 3.95 | 1.35 | 0.57 | 1.79 | 1.5 | 1.83 | 3.11 | 3.38 | 3.71 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 12 | 15 | 18 | 19 | 21 | 22 | 23 | 24 | 27 | 29 |
| Borrowings | 10 | 16 | 19 | 20 | 22 | 23 | 26 | 25 | 24 | 32 |
| Other Liabilities | 16 | 14 | 12 | 13 | 13 | 14 | 16 | 15 | 17 | 25 |
| Total Liabilities | 46 | 52 | 56 | 60 | 63 | 67 | 73 | 72 | 75 | 93 |
| Fixed Assets | 12 | 17 | 17 | 22 | 21 | 24 | 25 | 23 | 22 | 30 |
| CWIP | 3 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 30 | 32 | 37 | 38 | 41 | 43 | 47 | 49 | 53 | 63 |
| Total Assets | 46 | 52 | 56 | 60 | 63 | 67 | 73 | 72 | 75 | 93 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | 6 | 7 | 5 | 1 | 5 | 8 | 6 | 5 | 7 |
| Cash from Investing Activity | -5 | -6 | -2 | -4 | -2 | -4 | -4 | -1 | -1 | -7 |
| Cash from Financing Activity | 2 | -1 | -4 | -1 | 1 | -1 | -4 | -5 | -4 | 0 |
| Net Cash Flow | 0 | 0 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -1 | 0 | 5 | 0 | -1 | 0 | 4 | 5 | 4 | 0 |
| CFO/OP | 67 | 109 | 94 | 94 | 19 | 92 | 136 | 94 | 76 | 83 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 56 | 55 | 44 | 44 | 47 | 43 | 48 | 52 | 63 | 68 |
| Inventory Days | 134 | 132 | 130 | 170 | 160 | 124 | 121 | 116 | 99 | 91 |
| Days Payable | 85 | 64 | 48 | 59 | 50 | 41 | 45 | 42 | 44 | 45 |
| Cash Conversion Cycle | 105 | 123 | 126 | 155 | 157 | 127 | 125 | 127 | 118 | 114 |
| Working Capital Days | 48 | 40 | 34 | 42 | 57 | 49 | 39 | 37 | 40 | 38 |
| ROCE % | 15 | 15 | 16 | 10 | 6 | 9 | 7 | 9 | 10 | 10 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 34.45% | 34.45% | 34.45% | 34.45% | 34.45% | 34.45% | 34.45% | 34.74% | 35.07% | 35.08% | 41.98% | 41.98% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 52.66% | 52.83% | 53.51% | 53.37% | 53.8% | 54.29% | 54.5% | 54.29% | 54.17% | 54.31% | 54.17% | 54.29% |
| Others | 12.89% | 12.72% | 12.04% | 12.19% | 11.76% | 11.27% | 11.06% | 10.97% | 10.76% | 10.61% | 3.85% | 3.73% |
| No. of Shareholders | 4029 | 4119 | 4109 | 4317 | 4327 | 4404 | 4353 | 4407 | 4384 | 4371 | 4343 | 4337 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 7 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 39.64 | Buy |
| EMA (10) | 39.63 | Buy |
| SMA (20) | 39.43 | Buy |
| EMA (20) | 39.61 | Buy |
| SMA (50) | 39.61 | Buy |
| EMA (50) | 39.66 | Buy |
| SMA (100) | 39.53 | Buy |
| EMA (100) | 39.85 | Sell |
| SMA (200) | 40.71 | Sell |
| EMA (200) | 41.44 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.33 | Neutral |
| MACD (12,26,9) | -0.03 | Buy |
| Stochastic (14,3,3) | 56.94 | Neutral |
| ADX (14) | 19.49 | Neutral |
| Williams %R (14) | -42.1 | Neutral |
| ATR (14) | 2.38 | High Volatility |
| ROC (12) | 6.86 | Buy |
| Stoch RSI (14) | 75.95 | Neutral |
| UO (7,14,28) | 58.63 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22594b1c-9784-485a-b30f-ba707d848c01.pdf) |
| 2026-09-02 | [Reg. 30 Of SEBI (LODR) Regulations - Despatch Of Letters To Physical Shareholders Giving Weblink Of Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bae55bab-5ada-478b-8ff0-2e5d8e8f4ebf.pdf) |
| 2026-09-01 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3277b7ef-625f-449e-b8e9-1b0201b377b8.pdf) |
| 2026-09-01 | [42Nd AGM To Be Held On 24Th September 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08828fab-3d62-488f-b27f-f636409c14b1.pdf) |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dfee906-f25e-4c70-a8f5-adc5fc6718db.pdf) |
| 2026-08-19 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 19.08.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e93b7ed6-1703-487d-b93b-24a242e1fbac.pdf) |
| 2026-08-19 | [Intimation Of AGM To Be Held On 24.09.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fecab7f-2f56-47ab-b8d7-2a70fd3a1263.pdf) |
| 2026-08-19 | [Intimation Of Book Closure For AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=241a2265-d9b5-48d1-ace0-820404c1f8e5.pdf) |
| 2026-08-12 | [Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled On 19.08.2026Inter Alia To Consider And Approve Directors Report For Financial Year Ended March 31 2026 And Other Ancillary Matters With Permission Of The Chairman.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d63b8ac-24da-4049-8454-e3bd51c3b309.pdf) |
| 2026-08-06 | [Announcement Under Reg.30 Of SEBI (LODR) Reg. - Report Of RTA On Re-Lodgement Of Transfer Requests Of Physical Shares In Special Window - SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 Dated 30Th January 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c28fb7f9-b012-437d-93be-855a896a5bfc.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-29 | [Financial Results For First Quarter Ended On 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18e093de-c540-4ad4-8786-079c7ffd3707.pdf) |
| 2026-05-29 | [Audited Financial Results For Fourth Quarter And Financial Year Ended On 31.03.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1dcf158-3010-45b1-a8b4-b1ebcaf2267b.pdf) |
| 2026-02-10 | [Un-Audited Financial Results - December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afbfceb5-bf81-4764-9585-f57f3ded4668.pdf) |
| 2025-11-10 | [Unaudited Financial Results For Quarter End September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac32c10e-2b84-4368-a01c-facb87a22ee6.pdf) |
| 2025-08-05 | [Financial Results For Quarter End 30.06.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9874ee75-3029-40a3-bc30-08fb38be4214.pdf) |
| 2025-05-26 | [Financial Results For March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73c88b70-1c38-43a4-b8f9-6c441b7f9445.pdf) |
| 2025-02-10 | [Results - Financial Results For Quarter And Nine Months Ended December 30 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d10094a-f035-438a-88f2-900408e01c40.pdf) |
| 2024-10-29 | [Un-Audited Financial Results For Quarter Ended On 30Th September, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd07f440-a566-4fb5-ab96-940d692ee001.pdf) |
| 2024-08-12 | [Financial Results For June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9d57f27-b09c-4f16-81d9-0c80f7e3268e.pdf) |
| 2024-05-28 | [Audited Financial Result For The Year Ended 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a55825f-6916-4679-bfb1-32b5efaeddf0.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Feb - Maharashtra GST inspection/search concluded Feb 7, 2026; Cipla provided documents, no official order, no material impact. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 8 Feb - Maharashtra GST inspection/search concluded Feb 7, 2026; Cipla provided documents, no official order, no material impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e2d7405-f32d-48be-921c-cb43f85e3a8d.pdf) |
| 6 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bcbe1686-218f-465c-9774-09c5a0c52be7.pdf) |
| 5 Feb - GST inspection/search by Deputy Commissioner Maharashtra at Cipla facilities on 5 Feb 2026; probes tax, ITC, refunds. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 5 Feb - GST inspection/search by Deputy Commissioner Maharashtra at Cipla facilities on 5 Feb 2026; probes tax, ITC, refunds.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/651ea27d-abac-4813-b309-dc1f762fbc17.pdf) |
| 4h - Cipla USA recalls unexpired Lanreotide Injection batches, causing temporary market supply disruption (09-Mar-2026). | [Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A. 4h - Cipla USA recalls unexpired Lanreotide Injection batches, causing temporary market supply disruption (09-Mar-2026).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2f47f254-c4df-492e-96b6-f2700ee8f39e.pdf) |
| 4 Feb - Schedule of Analyst / Institutional Investor Meeting with the Company | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Feb - Schedule of Analyst / Institutional Investor Meeting with the Company](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9605570e-8321-494a-927d-fd5058974dfb.pdf) |
| 26 Feb - ESG rating downgraded 66→65 for FY2024–25; received 25 Feb 2026; linked to Cipla USA recall. | [Intimation Under Regulation 30 Read With Schedule III Of The SEBI (LODR) Regulations, 2015 26 Feb - ESG rating downgraded 66→65 for FY2024–25; received 25 Feb 2026; linked to Cipla USA recall.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e48b0a25-d4fc-431a-b8df-3039a2eaeebd.pdf) |
| 24 Feb - Newspaper advertisement for Notice of Postal Ballot and e-voting information | [Announcement under Regulation 30 (LODR)-Newspaper Publication 24 Feb - Newspaper advertisement for Notice of Postal Ballot and e-voting information](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85fb936e-988b-4cad-9eda-fa93b6a76767.pdf) |
| 21 Feb - USFDA classified Rodopi, Greece facility OAI (21 Feb 2026); affects Lanreotide Injection supply to Cipla USA. | [Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A. 21 Feb - USFDA classified Rodopi, Greece facility OAI (21 Feb 2026); affects Lanreotide Injection supply to Cipla USA.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e1107f95-0491-426e-ad83-9e31782b72eb.pdf) |
| 21 Apr - Rishi Techtex confirms it is not a large corporate as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 21 Apr - Rishi Techtex confirms it is not a large corporate as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cd59f45f-e591-4980-bffc-2c394cb3550a.pdf) |
| 2 Mar - Cipla Middle East Company incorporated in Saudi Arabia effective 1 March 2026; 100% owned by Cipla (EU) Limited. | [Announcement under Regulation 30 (LODR)-Acquisition 2 Mar - Cipla Middle East Company incorporated in Saudi Arabia effective 1 March 2026; 100% owned by Cipla (EU) Limited.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0d6c6632-69e8-422c-8cf4-e02b52ae5852.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b6dc9897-3c64-4c9e-bdd2-2c4734877009.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b053ace1-599a-4738-a4c7-0168aaf72a82.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ea9d3f9-fdfe-4f40-9d9e-057a5018ec8f.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae36e932-1fad-430d-86cd-068199e717b5.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/28b4fd36-0ffb-4f8e-8f27-5a52843fb9d0.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e02f8b42-ef23-4508-8224-9b6858e76569.pdf) |
| Nov 2019 | [Concall - Nov 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aaa3665e-90d2-48c8-a456-4363ae4b059e.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/dbc47dcc-0024-4f2b-8889-f65703c014e6.pdf) |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/11/b633e1aa-280f-43ca-9c08-c99ef594057d.pdf) |
| Nov 2016 | [Concall - Nov 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3BAD1874_BC7B_465E_98C8_4F30B20F354F_165114.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/674f8305-0979-4722-ad6c-b7915c00c1d8.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/239a3013-99cf-4e81-8200-f3a0c54d16e0.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9ec11f08-4ca3-4060-8cd4-2cfad0af4959.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a553be3-a2ef-416f-be80-9b66bed406e2.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b1af9c1-e37f-4ff0-8583-a71bff16fb42.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/53a0cf31-f7e7-41c8-b905-9a9e4e207ca9.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500087/74053500087.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/523021/74859523021.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500087/69187500087.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/523021/69869523021.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:05.359Z.